Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of tyr-somatostatin-14 in China, also supports custom service. Welcome to wholesale bulk high quality tyr-somatostatin-14 from our factory. Contact us for more details.
| Description | Tyr-Somatostatin-14 is a somatostatin analog with an additional tyrosine residue at the N-terminus of native somatostatin-14 (Somatostatin-14, SST-14), CAS number 58100-03-1. The native somatostatin-14 sequence is AGCKNFFWKTFTSC (14aa, Cys3-Cys14 disulfide-bridged cyclic), and Tyr-Somatostatin-14 adds a tyrosine (Y) at its N-terminus, forming the 15-amino-acid YAGCKNFFWKTFTSC sequence (Cys4-Cys15 disulfide-bridged cyclic). Somatostatin is an important neuroendocrine regulatory peptide that exerts inhibitory effects on growth hormone, insulin, glucagon, and various gastrointestinal hormone secretion by binding to somatostatin receptors (SSTR1-5). The introduction of an N-terminal tyrosine provides a site for radioiodine labeling (such as ¹²⁵I, ¹³¹I) for this peptide, which can be used in receptor binding experiments, autoradiography, and in vivo SSTR expression imaging studies. Tyr-Somatostatin-14 retains high-affinity binding capability to SSTRs and is widely used in SSTR targeting research of neuroendocrine tumors (such as carcinoid tumors, islet cell tumors), receptor pharmacology experiments, and radiopharmaceutical development. |
| Molecular formula | C₈₅H₁₁₃N₁₉O₂₁S₂ |
| Molecular weight (Da) | 1801.05 |
| Structure type | Cyclic peptide (Cys4-Cys15 disulfide bridge, N-terminal tyrosine-labeled somatostatin analog) |
| Solubility | Freely soluble in water, PBS |
| Storage | Condition Powder at -20°C, dry and protected from light |
Product Basic Information Table
| Product Standard English Name | Product Abbreviation / Alias | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| Tyr-Somatostatin-14 | Tyrosine-modified somatostatin-14; Tyr-SS-14 | Somatostatin receptor ligand, neuropeptide, endocrine regulation, tumor imaging | Native somatostatin-14 N-terminally modified with tyrosine, retaining high affinity for SSTR receptors; inhibits secretion of growth hormone and glucagon, and can be radioiodinated for imaging of receptor-positive tumors | C₇₆H₁₀₄N₁₈O₁₉S₂ | 1636.72 | ~1637.9 | Acetate | 14 |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-TYR-SS14 | White powder | Store at -20°C, sealed, dry and protected from light. Aliquot for storage. | Stable for 1 month at 2–8°C in sealed dry condition; stable for shipping at ambient temperature. | Stable for 7 days at 4°C. Soluble in dilute acetic acid and PBS. Intramolecular disulfide bond is sensitive to strong reducing agents and prone to cleavage and inactivation. Optimal receptor binding activity at physiological pH. | Stable for 2 years at -20°C, dry and protected from light. |
Functional Description
| Product Code | Frontend Short Summary (for search list display) | Detailed Biological Function Description | Applicable Research Areas (comma-separated) | Targets / Pathways |
| PEP-TYR-SS14 | Tyrosine-modified somatostatin-14 for receptor binding and tumor imaging | Tyr-Somatostatin-14 is a modified peptide with a tyrosine added to the N-terminus of native somatostatin-14. It fully retains high affinity for somatostatin receptors (SSTR1–5) and inhibits secretion of growth hormone, insulin and glucagon. The N-terminal tyrosine allows convenient radioiodination for imaging diagnosis and receptor research of SSTR-positive tumors. | Endocrine disease research, tumor molecular imaging, neuropeptide research, receptor pharmacology, nuclear medicine diagnosis | Somatostatin receptors (SSTR); GPCR signaling pathway; hormone secretion regulation |
Hot Tags: tyr-somatostatin-14, China tyr-somatostatin-14 manufacturers, suppliers, factory, 203716-10-3, 651328-78-8, CAS 203716 10 3, CAS 395069 92 8, Tetralysine, therapeutic and pharmaceutical peptides
